RODENTHOR Rodenticides

Hazard statements (CLP)

H373

Code

Statements

H373

May cause damage to organs through prolonged or repeated exposure

SECTION 2: Hazards identification

Hazard statements

This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. H373: May cause damage to organs through prolonged or repeated exposure.

SUSMP Classification

S6

ADG classification

None allocated. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA or IMSBC criteria.

UN Number

None allocated

2.1 Classification of the substance or mixture

Specific target organ toxicity (Repeated exposure) Category 2

Signal word

WARNING

Prevention

P102: Keep out of reach of children. P260: Do not breathe dusts.

Response

P314: Get medical advice or attention if you feel unwell.

Disposal

P501: Dispose of small quantities and empty containers by wrapping with paper and putting in garbage. For larger quantities, if recycling or reclaiming is not possible, use a commercial waste disposal service. ® Registered trademark of Ensystex, Inc. used under licence by Ensystex Australasia Pty Ltd and Ensystex New Zealand Ltd. Emergency Overview Physical Description & colour: Solid extruded 10 g or 15 g blue wax block or; 10 g or 15 g tea bag with blue paste. Odour: Mild characteristic odour.

Health hazards

Ingestion of brodifacoum is initially asymptomatic and may continue as such even with prolonged alterations in prothrombin time. No gastrointestinal tract or other symptomatology occurs. Coagulation disturbances may become evident a few days after ingestion and may be detected only by laboratory studies. In severe poisoning, gum-bleeding, epistaxis, petechiae, ecchymoses, haematomata, blood in urine and faeces, and genital haemorrhage may occur. Internal bleeding and cerebral haemorrhage may complicate the patient's prognosis. Danger of cumulative effects.

Potential health effects

Symptoms and Effects No adverse health effects are expected if the product is handled in accordance with this Safety Data Sheet and the product label. Symptoms that may occur if the product is mishandled are: • Mild Exposure: Reduction in the clotting ability of the blood, detectable only by medical analysis. • Moderate Exposure: Bleeding from gums, tendency to bruise easily, blood present in faeces and/or urine, excessive bleeding from minor cuts. • Severe Exposure: Severe intestinal bleeding and/or internal bleeding resulting in shock, coma and even death in very severe cases. Inhalation: Short term exposure: Available data indicates product is not harmful. Product is unlikely to cause any discomfort or irritation. Long Term exposure: No data for health effects associated with long term inhalation. Skin Contact: Short term exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However, product may be mildly irritating, but is unlikely to cause anything more than mild discomfort which should disappear once contact ceases. Long Term exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short term exposure: This product may be mildly irritating to eyes but is unlikely to cause anything more than mild discomfort which should disappear once product is removed. Long Term exposure: No data for health effects associated with long term eye exposure. Ingestion: Short term exposure: Significant oral exposure is considered to be unlikely. The denatonium benzoate in the product makes it very unpalatable to humans. However, this product is an oral irritant. Symptoms may include burning sensation and reddening of skin in mouth and throat. Other symptoms may also become evident, but all should disappear once exposure has ceased. Long Term exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.